Genetics of Alzheimer's disease: First identification of a strong recessive component
A new study from deCODE genetics and collaborators is the first to uncover a strong recessive component in Alzheimer's disease.
Jun 21, 2024
0
1
A new study from deCODE genetics and collaborators is the first to uncover a strong recessive component in Alzheimer's disease.
Jun 21, 2024
0
1
The US Federal Trade Commission (FTC) announced an agreement on Friday allowing American drug manufacturer Amgen to proceed with its $28 billion takeover of Horizon Therapeutics.
Sep 1, 2023
0
4
US regulators filed a lawsuit Tuesday to block biopharmaceutical firm Amgen's proposed $28 billion takeover of drug maker Horizon Therapeutics, saying the transaction would harm consumers.
May 16, 2023
0
33
US biopharmaceutical firm Amgen said Monday it has reached agreement to acquire Horizon Therapeutics, which specializes in medicine for rare and auto-immune diseases, for $27.8 billion.
Dec 12, 2022
0
1
Amgen has agreed to acquire the global rights to Otezla, a drug used for the treatment of psoriasis and psoriatic arthritis, for $13.4 billion in cash, Bristol Myers Squibb said Monday.
Aug 26, 2019
0
2
Federal regulators on Friday approved the first alternative version of the second-best selling drug in the world, Humira, the blockbuster injection used to treat rheumatoid arthritis and other inflammatory diseases.
Sep 23, 2016
0
3
Astronauts know their bodies will be tested during time spent on the International Space Station, from the 15 daily sunrises and sunsets wreaking havoc on their circadian rhythms to the lack of gravity that weakens bone density ...
May 26, 2016
0
41
US biotech company Medivation has opened the door to being bought by either Pfizer or Amgen, a person familiar with the matter told AFP Tuesday.
May 10, 2016
0
1
Biotech drug giant Amgen has made two much-needed deals to replenish its stock of medicines in development as new competition to its lucrative biotech drugs threatens future revenue.
Sep 16, 2015
0
5
Swiss drug maker Novartis says it will cooperate with California-based biotech giant Amgen to develop and sell neuroscience treatments for illnesses and ailments like Alzheimer's disease and migraine headaches.
Sep 2, 2015
0
12